p53 Phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14(ARF), and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation

Cancer Research

Volumn 60, Issue 4, 2000, Pages 896-900

  Buschmann, Thomas ^a   Adler, Victor ^a   Matusevich, Ekaterina ^a   Fuchs, Serge Y ^a   Ronai, Ze'ev ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE; PROTEIN MDM2; PROTEIN P300; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

ACETYLATION; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; ULTRAVIOLET IRRADIATION;

CELL CYCLE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0034652718     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Reich, N., Oren, M., and Levine, A. J. Two distinct mechanisms regulate the levels of a cellular tumor antigen. p53. Mol. Cell. Biol., 3: 2143-2150, 1983.
2. Hall, P., McKee, P., Menage, H., Dover, R., and Lane, D. P. High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8: 203-207, 1993.
3. Meek, D. W. Multiple phosphorylation and the integration of stress signals at p53. Cell Signal, 10: 159-166, 1998.
4. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. MDM2 promotes the rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
5. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by Mdm2. Nature (Lond.), 387: 299-303, 1997.
6. Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., and Ronai, Z. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev., 12: 2658-2663, 1998.
7. Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA, 95: 10541, 10546, 1998.
8. Pomerantz, J., Schreiber-Agus, N., Liegeois, N., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H., Cordon-Cardo, C., and DePinho, R. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92: 713-723. 1998.
9. Grossman, S., Perez, M., Kung, A., Joseph, M., Mansur, C., Xizo, Z., Kumar, S., Howley, P. M., and Livingston, D. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell, 2: 405-415, 1998.
10. Huang, C., Ma, W., Maxiner, A., Sun, Y., and Dong, Z. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J. Biol. Chem., 274: 12229-12235, 1999.
11. Shieh, S., Ikeda, M., Taya, Y., and Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 91: 325-334, 1997.
12. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (Washington DC), 281: 1674-1677, 1998.
13. Milne, D. M., Campbell, L. E., Campbell, D. G., and Meek, D. W. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNKI. J. Biol. Chem., 270: 5511-5518, 1995.
14. McKendrick, L., Milne, D., and Meek, D. W. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable. Mol. Cell. Biochem., 191: 187-199, 1999.
15. Chernov, M., Ramana, C., Adler, V., and Stark, G. Stabilization and activation of p53 are regulated independently by different phosphorylation event. Proc. Natl. Acad. Sci. USA, 95: 2284-2289, 1998.
16. Price, B., Hughes-Davis, L., and Parks, S. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. Oncogene, 11: 73-80, 1995.
17. Sakaguchi, K., Herrera, J., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C., and Apella, E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev., 12: 2831-2841, 1998.
18. Canman, C., Gilmer, T., Coutts, S., and Kastan, M. B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9: 600-611, 1995.
19. Halazonetis, T., Davis, L., and Kandil, A. Wild-type p53 adopts a "mutant"-like conformation when bound to DNA. EMBO J., 12: 1021-1028, 1993.
20. Siliciano, J., Canman, C., Taya, Y., Sakaguchi, K., Apella, E., and Kastan, M. B. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev., 11: 3471-3481, 1997.
21. Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., and Herrlich, P. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene, 18: 1723-1732, 1999.